Skip to content
akaturk Academic measurement
Sign in Register

Academician

SEVİM DALVA AYDEMİR

ÖĞRETİM GÖREVLİSİ

ANKARA ÜNİVERSİTESİ BİYOTEKNOLOJİ ENSTİTÜSÜ BİYOTEKNOLOJİ ANABİLİM DALI

  • Ana Dal Fen Bilimleri ve Matematik Temel Alanı
  • Yan Dal Biyoloji

A quick look at recorded outputs — details below.

  • Articles 6
  • Projects 0
  • Books 0
  • Proceedings 0
  • Patents 0
  • Artistic 0
Scopus (SJR) Q1 3 Q2 3 Q3 2 Q4 0
WoS (JCR) Q1 1 Q2 5 Q3 0 Q4 2
TR Index 0 articles

Field+year+type normalized OpenAlex percentiles — not Clarivate ESI / SciVal.

Top 1% articles 0
Top 10% articles 0
Avg percentile 54.4%
Top 1% share 0.0%
Top 10% share 0.0%

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

Index filters

6 publications total

Scopus (SJR)
Q1 3 Q2 3 Q3 2 Q4 0
WoS (JCR)
Q1 1 Q2 5 Q3 0 Q4 2
TR Index
0 articles

Article list

  1. 2022 Effect of CD34+ Total/Myeloid CD34+ Cell Progenitors and B-Lymphoid Progenitors Within the Bone Marrow Grafts on the Hematopoietic Recovery After Hematopoietic Stem Cell Transplantation Experimental and Clinical Transplantation DOI 10.6002/ect.2022.0210 YÖKSİS SJR Q3 JCR Q4 OpenAlex 22.5%
  2. 2021 Significance of inhibitory maternal killer-cell immunoglobulin-like receptor (KIR) and fetal KIR ligand genotype combinations in placenta related obstetric complications Journal of Reproductive Immunology DOI 10.1016/j.jri.2021.103425 YÖKSİS SJR Q1 JCR Q2 OpenAlex 46.3%
  3. 2019 Toward In Vitro Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735, an Aurora Kinase Inhibitor OMICS: A Journal of Integrative Biology DOI 10.1089/OMI.2019.0050 YÖKSİS SJR Q2 JCR Q2 OpenAlex 56.4%
  4. 2015 Investigating and targeting chronic lymphocytic leukemia metabolism with the human immunodeficiency virus protease inhibitor ritonavir and metformin LEUKEMIA & LYMPHOMA DOI 10.3109/10428194.2014.922180 YÖKSİS SJR Q2 JCR Q2 OpenAlex 82.3%
  5. 2015 Targeting the Metabolic Plasticity of Multiple Myeloma with FDA-Approved Ritonavir and Metformin Clinical Cancer Research DOI 10.1158/1078-0432.CCR-14-1088 YÖKSİS SJR Q1 JCR Q1 OpenAlex 82.3%
  6. 2013 AS160 Variant 2 Expression Enables Constitutive GLUT4 Plasma Membrane Localization and Elevated Glucose Consumption in Multiple Myeloma Cancer Metabolism DOI 10.1186/2049-3002-1-14 YÖKSİS OpenAlex 74.4%
  7. 2022 Effect of CD34+ Total/Myeloid CD34+ Cell Progenitors and B-Lymphoid Progenitors Within the Bone Marrow Grafts on the Hematopoietic Recovery After Hematopoietic Stem Cell Transplantation. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation DOI 10.6002/ect.2022.0210 YÖKSİS SJR Q3 JCR Q4 OpenAlex 22.5%
  8. 2021 Significance of inhibitory maternal killer-cell immunoglobulin-like receptor (KIR) and fetal KIR ligand genotype combinations in placenta related obstetric complications Journal of Reproductive Immunology DOI 10.1016/j.jri.2021.103425 YÖKSİS SJR Q1 JCR Q2 OpenAlex 46.3%
  9. 2019 Toward In Vitro Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735, an Aurora Kinase Inhibitor OMICS: A Journal of Integrative Biology DOI 10.1089/omi.2019.0050 YÖKSİS SJR Q2 JCR Q2 OpenAlex 56.4%

Back to academicians